Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Xortx Therapeutics Inc (XRTX)

Xortx Therapeutics Inc (XRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,798
  • Shares Outstanding, K 1,999
  • Annual Sales, $ 0 K
  • Annual Income, $ -2,160 K
  • EBIT $ -5 M
  • EBITDA $ -5 M
  • 60-Month Beta 0.70
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.96

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.2500 unch
on 11/15/24
2.3500 -46.81%
on 10/16/24
-0.6200 (-33.16%)
since 10/15/24
3-Month
1.0900 +14.68%
on 08/27/24
2.9799 -58.05%
on 08/29/24
-0.2400 (-16.11%)
since 08/15/24
52-Week
1.0900 +14.68%
on 08/27/24
7.0000 -82.14%
on 03/07/24
-1.1600 (-48.13%)
since 11/15/23

Most Recent Stories

More News
XORTX Sponsored Study Presented at the American Society of Nephrology – Kidney Week 2024

XRTX.VN : 1.950 (unch)
XRTX : 1.3900 (-0.71%)
XORTX Announces Closing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement

XRTX.VN : 1.950 (unch)
XRTX : 1.3900 (-0.71%)
XORTX Announces Pricing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement

XRTX.VN : 1.950 (unch)
XRTX : 1.3900 (-0.71%)
XORTX Initiates Precision Medicine Program

XRTX.VN : 1.950 (unch)
XRTX : 1.3900 (-0.71%)
XORTX Announces Submission to European Medicines Agency

Scientific Advice from EMA Committee for Medicinal Products for Human Use Requested...

XRTX.VN : 1.950 (unch)
XRTX : 1.3900 (-0.71%)
XORTX Announces Positive Topline Results from Pharmacokinetics Bridging Clinical Trial

Clinical Trial Shows Substantially Improved Bioavailiability...

XRTX.VN : 1.950 (unch)
XRTX : 1.3900 (-0.71%)
XORTX Announces Pre-Phase 3 Meeting Request with US Food and Drug Administration (FDA)

CALGARY, Alberta, July 07, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a...

XRTX.VN : 1.950 (unch)
XRTX : 1.3900 (-0.71%)
XORTX to Present at BIO International Convention 2022

CALGARY, Alberta, June 13, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a...

XRTX.VN : 1.950 (unch)
XRTX : 1.3900 (-0.71%)
XORTX Welcomes New Member to the Board of Directors and Appoints Chair

CALGARY, Alberta, June 06, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a...

XRTX.VN : 1.950 (unch)
XRTX : 1.3900 (-0.71%)
XORTX Receives Small and Medium Enterprise Status for the European Union

CALGARY, Alberta, April 20, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a...

XRTX.VN : 1.950 (unch)
XRTX : 1.3900 (-0.71%)

Business Summary

XORTX Therapeutics Inc. is a pharmaceutical therapeutics company. It focused on developing therapies to treat progressive kidney disease. XORTX Therapeutics Inc. is based in CALGARY, Alberta.

See More

Key Turning Points

3rd Resistance Point 1.6067
2nd Resistance Point 1.5133
1st Resistance Point 1.4567
Last Price 1.3900
1st Support Level 1.3067
2nd Support Level 1.2133
3rd Support Level 1.1567

See More

52-Week High 7.0000
Fibonacci 61.8% 4.7424
Fibonacci 50% 4.0450
Fibonacci 38.2% 3.3476
Last Price 1.3900
52-Week Low 1.0900

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar